$USNU
Elite Health Systems Inc.

2021 Q1 Form 10-Q Financial Statement

#000114036121017645 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $1.061M $747.0K
YoY Change 42.03% -11.18%
Cost Of Revenue $86.00K $79.00K
YoY Change 8.86% -8.14%
Gross Profit $975.0K $668.0K
YoY Change 45.96% -11.52%
Gross Profit Margin 91.89% 89.42%
Selling, General & Admin $298.0K $302.0K
YoY Change -1.32% -1.95%
% of Gross Profit 30.56% 45.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $384.0K $381.0K
YoY Change 0.79% -3.3%
Operating Profit $677.0K $366.0K
YoY Change 84.97% -18.12%
Interest Expense $2.000K $11.00K
YoY Change -81.82% -62.07%
% of Operating Profit 0.3% 3.01%
Other Income/Expense, Net -$133.0K
YoY Change
Pretax Income $544.0K $233.0K
YoY Change 133.48% -11.07%
Income Tax $252.0K $58.00K
% Of Pretax Income 46.32% 24.89%
Net Earnings $292.0K $175.0K
YoY Change 66.86% -5.91%
Net Earnings / Revenue 27.52% 23.43%
Basic Earnings Per Share $0.04 $0.02
Diluted Earnings Per Share $0.04 $0.02
COMMON SHARES
Basic Shares Outstanding 7.792M 7.792M
Diluted Shares Outstanding 7.792M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.543M $1.734M
YoY Change 46.66% 21.51%
Cash & Equivalents $2.543M $1.734M
Short-Term Investments
Other Short-Term Assets $80.00K $96.00K
YoY Change -16.67% -39.62%
Inventory
Prepaid Expenses
Receivables $828.0K $396.0K
Other Receivables $0.00 $1.204M
Total Short-Term Assets $3.451M $3.430M
YoY Change 0.61% -23.9%
LONG-TERM ASSETS
Property, Plant & Equipment $86.00K $120.0K
YoY Change -28.33% -21.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $161.0K $222.0K
YoY Change -27.48% 5.21%
Other Assets $1.077M $1.798M
YoY Change -40.1%
Total Long-Term Assets $1.163M $1.918M
YoY Change -39.36% -11.65%
TOTAL ASSETS
Total Short-Term Assets $3.451M $3.430M
Total Long-Term Assets $1.163M $1.918M
Total Assets $4.614M $5.348M
YoY Change -13.72% -19.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $166.0K $268.0K
YoY Change -38.06% 13.56%
Accrued Expenses $40.00K $37.00K
YoY Change 8.11% 12.12%
Deferred Revenue $588.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $620.0K
YoY Change -100.0% -57.21%
Total Short-Term Liabilities $322.0K $1.912M
YoY Change -83.16% -19.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $67.00K $108.0K
YoY Change -37.96% -25.52%
Total Long-Term Liabilities $67.00K $108.0K
YoY Change -37.96% -85.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $322.0K $1.912M
Total Long-Term Liabilities $67.00K $108.0K
Total Liabilities $389.0K $2.020M
YoY Change -80.74% -41.97%
SHAREHOLDERS EQUITY
Retained Earnings $1.047M $150.0K
YoY Change 598.0%
Common Stock $3.178M $3.178M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.225M $3.328M
YoY Change
Total Liabilities & Shareholders Equity $4.614M $5.348M
YoY Change -13.72% -19.92%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $292.0K $175.0K
YoY Change 66.86% -5.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $214.0K $752.0K
YoY Change -71.54% 65.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $388.0K $17.00K
YoY Change 2182.35% -107.46%
Cash From Investing Activities $388.0K $17.00K
YoY Change 2182.35% -107.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -89.00K -370.0K
YoY Change -75.95% 16.35%
NET CHANGE
Cash From Operating Activities 214.0K 752.0K
Cash From Investing Activities 388.0K 17.00K
Cash From Financing Activities -89.00K -370.0K
Net Change In Cash 513.0K 399.0K
YoY Change 28.57% -533.7%
FREE CASH FLOW
Cash From Operating Activities $214.0K $752.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
166000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
170000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
828000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
346000
CY2021Q1 us-gaap Accounts Receivable Related Parties Noncurrent
AccountsReceivableRelatedPartiesNoncurrent
916000
CY2020Q4 us-gaap Accounts Receivable Related Parties Noncurrent
AccountsReceivableRelatedPartiesNoncurrent
912000
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
116000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
111000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3100000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3100000
CY2021Q1 us-gaap Assets
Assets
4614000
CY2020Q4 us-gaap Assets
Assets
4173000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
3451000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
3007000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2030000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2543000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
399000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
513000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2030000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1335000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2543000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1734000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7792185
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7792185
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7792185
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7792185
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
78000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
78000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-120000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
31000
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
161000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
160000
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
89000
CY2020Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
620000
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2021Q1 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
86000
CY2020Q1 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
79000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
544000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
233000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-139000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-146000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-19000
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-6000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
362000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
482000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40000
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-179000
CY2020Q1 us-gaap Interest Expense
InterestExpense
11000
CY2021Q1 us-gaap Interest Expense
InterestExpense
2000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
2000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
11000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
34000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
104000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
24000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
46000
CY2020Q1 us-gaap Lease Income
LeaseIncome
2000
CY2021Q1 us-gaap Lease Cost
LeaseCost
5000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4614000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4173000
CY2020Q4 us-gaap Liabilities
Liabilities
487000
CY2021Q1 us-gaap Liabilities
Liabilities
389000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
410000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
322000
CY2020Q1 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
0
CY2021Q1 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
0
CY2021Q1 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
0
CY2020Q4 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
532000
CY2020Q1 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
1204000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
752000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
214000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
539000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
175000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
388000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-89000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-370000
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05850
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
96000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
97000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
40000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
40000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
384000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
381000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
94000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
120000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
677000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
366000
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
80000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
99000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1072000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1077000
CY2020Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-9000
CY2021Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
0
CY2020Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
172000
CY2021Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
144000
CY2021Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2020Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
36000
CY2021Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
532000
CY2020Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
216000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86000
CY2020Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
370000
CY2021Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
89000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1047000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
508000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1061000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
747000
CY2021Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
8000
CY2020Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
24000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
302000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
298000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3686000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4225000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
U.S. NeuroSurgical Holdings, Inc.
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001089815
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7792185
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 usnu Income Loss From Equity Method Investments Net
IncomeLossFromEquityMethodInvestmentsNet
-146000
CY2021Q1 usnu Income Loss From Equity Method Investments Net
IncomeLossFromEquityMethodInvestmentsNet
-139000
CY2020Q1 usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
8000
CY2021Q1 usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
10000
CY2020Q4 usnu Amount Of Guarantee Obligations Noncurrent
AmountOfGuaranteeObligationsNoncurrent
11000
CY2021Q1 usnu Amount Of Guarantee Obligations Noncurrent
AmountOfGuaranteeObligationsNoncurrent
11000
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 usnu Renovation Installation And Operation Agreement Period
RenovationInstallationAndOperationAgreementPeriod
P14Y
CY2021Q1 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
86000
CY2020Q1 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
1324000
CY2020Q1 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
754000
CY2021Q1 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
96000

Files In Submission

Name View Source Status
0001140361-21-017645-index-headers.html Edgar Link pending
0001140361-21-017645-index.html Edgar Link pending
0001140361-21-017645.txt Edgar Link pending
0001140361-21-017645-xbrl.zip Edgar Link pending
brhc10024568_10q.htm Edgar Link pending
brhc10024568_ex31-1.htm Edgar Link pending
brhc10024568_ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usnu-20210331.xml Edgar Link completed
usnu-20210331.xsd Edgar Link pending
usnu-20210331_cal.xml Edgar Link unprocessable
usnu-20210331_def.xml Edgar Link unprocessable
usnu-20210331_lab.xml Edgar Link unprocessable
usnu-20210331_pre.xml Edgar Link unprocessable